Guardant Health (GH) Capital Expenditures (2017 - 2026)

Guardant Health has disclosed Capital Expenditures across 10 years of filings, most recently posting $11.8 million for Q2 2026.

• In Q2 2026, Capital Expenditures rose 108.16% year-over-year to $11.8 million; the TTM figure through Jun 2026 stood at $55.5 million (up 67.37% YoY), while the FY2025 annual figure was $48.3 million, up 37.68% from the prior year.
• Capital Expenditures came in at $11.8 million for Q2 2026 at Guardant Health, up from $5.6 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $27.8 million in Q4 2025 to a low of $2.4 million in Q3 2023.
• Average Capital Expenditures over 5 years is $11.0 million, with a median of $7.5 million recorded in 2023.
• Year-over-year, Capital Expenditures tumbled 89.08% in 2023 and jumped 362.96% in 2024.
• Over 5 years, Capital Expenditures stood at $10.0 million in 2022, then slumped by 59.23% to $4.1 million in 2023, then jumped by 362.96% to $18.9 million in 2024, then surged by 47.54% to $27.8 million in 2025, then tumbled by 57.77% to $11.8 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $11.8 million in Q2 2026, $5.6 million in Q1 2026, and $27.8 million in Q4 2025.